Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Arthritis Research & Therapy
|
September 29, 2023
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start
Adrian Ciurea, Oliver Distler, Kenneth Kwok, et al.
Plos One
|
March 23, 2012
Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the Psychomotor Vigilance Test
Julian Lim, Richard Ebstein, Chun-Yu Tse, et al.
The Journal of Rheumatology
|
July 15, 2022
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial
Emilce E Schneeberger, Gustavo Citera, Dario Ponce de Leon, et al.
The Journal of Rheumatology
|
March 2, 2022
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials
Louis Bessette, Eduardo Mysler, Cassandra D Kinch, et al.
Clinical and Experimental Rheumatology
|
November 18, 2015
Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III
Stanley B Cohen, Andrew Koenig, Lisy Wang, et al.
Rheumatology and Therapy
|
July 3, 2024
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
Grace C Wright, Eduardo Mysler, Kenneth Kwok, et al.
Rheumatology and Therapy
|
June 28, 2018
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
Stephen Hall, Peter Nash, Maureen Rischmueller, et al.
RMD Open
|
August 6, 2016
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
Roy M Fleischmann, Tom W J Huizinga, Arthur F Kavanaugh, et al.
International Journal of Rheumatic Diseases
|
January 10, 2018
Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial
Zhanguo Li, Yuan An, Houheng Su, et al.
Digestive Diseases and Sciences
|
August 21, 2020
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Remo Panaccione, John D Isaacs, Lea Ann Chen, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Arthritis Research & Therapy
|
September 29, 2023
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start
Adrian Ciurea, Oliver Distler, Kenneth Kwok, et al.
Plos One
|
March 23, 2012
Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the Psychomotor Vigilance Test
Julian Lim, Richard Ebstein, Chun-Yu Tse, et al.
The Journal of Rheumatology
|
July 15, 2022
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial
Emilce E Schneeberger, Gustavo Citera, Dario Ponce de Leon, et al.
The Journal of Rheumatology
|
March 2, 2022
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials
Louis Bessette, Eduardo Mysler, Cassandra D Kinch, et al.
Clinical and Experimental Rheumatology
|
November 18, 2015
Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III
Stanley B Cohen, Andrew Koenig, Lisy Wang, et al.
Rheumatology and Therapy
|
July 3, 2024
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
Grace C Wright, Eduardo Mysler, Kenneth Kwok, et al.
Rheumatology and Therapy
|
June 28, 2018
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
Stephen Hall, Peter Nash, Maureen Rischmueller, et al.
RMD Open
|
August 6, 2016
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
Roy M Fleischmann, Tom W J Huizinga, Arthur F Kavanaugh, et al.
International Journal of Rheumatic Diseases
|
January 10, 2018
Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial
Zhanguo Li, Yuan An, Houheng Su, et al.
Digestive Diseases and Sciences
|
August 21, 2020
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Remo Panaccione, John D Isaacs, Lea Ann Chen, et al.
Page
of 6